Continuous spray scalp therapy and dispensing systems for same

• US 20080206156A1
• Filed: 02/22/2007
• Published: 08/28/2008
• Est. Priority Date: 02/22/2007
• Status: Abandoned Application

• Current Assignee: Peter J. Cronk
• Original Assignee: Peter J. Cronk
• Inventors: Cronk, Peter J.
• Application Number:
  US11/677,777
• Publication Number:
  US 20080206156A1
• Time in Patent Office: Days
• US Class Current: 424/45
• CPC Class Codes: A61K 8/046 Aerosols; Foams
• CPC Class Codes: A61K 8/4953 containing pyrimidine ring derivatives, e.g. minoxidil
• CPC Class Codes: A61P 17/14 for baldness or alopecia
• CPC Class Codes: A61Q 7/00 Preparations for affecting hair growth

Abstract

The present invention relates to continuous spray medications involving the scalp, such as minoxidil, finesteride, copper peptides, DHT inhibitors and androgen receptor blockers, for example, in an amount sufficient to stimulate or maintain hair growth. The scalp medication is disposed within a pharmacologically acceptable carrier solution. In further embodiments, the spray scalp medication is dispensed within a product bag containing the medication in liquid form. The product bag is disposed within a container and includes a sheet of gas impervious material having a barrier layer therein. A gaseous propellant is also disposed within the container and is substantially separated from the medication. The valve assembly is selectively operated to produce a fine mist of said medication which is non-chilling, continuous and even.

Claims

1. A fine mist spray delivery system in combination with a scalp medication, comprising:

a portable container having a gas impervious container wall;

a pressure source disposed within said container;

a selectively operable valve assembly affixed to said container; and

a product bag containing said scalp medication in liquid form, said product bag product disposed within said container and including a sheet of gas-impervious material having a barrier layer therein, said pressure source being substantially separated from said medication by at least said barrier layer, said scalp medication comprising a hair growth stimulator or hair growth maintenance active ingredient in an amount sufficient to stimulate or maintain hair growth disposed within a pharmacologically acceptable carrier solution, said scalp medication being dispensable at any angle, including when said value assembly is up-side down, to produce said fine mist of said scalp medication in a continuous fashion.

2. The delivery system of claim 1 wherein said active ingredient comprises 2-15% minoxidil.

3. The delivery system of claim 1 wherein said continuous spray is non-chilling (98.6°

F.±

5°

F.) upon contact with skin, and is delivered quietly, under 60 decibels.

4. The delivery system of claim 1 wherein said valve assembly is a two-way valve.

5. The delivery system of claim 1 wherein said product bag comprises at least one gusset.

6. A method of treating alopecia, comprising:

providing a delivery system comprising a valve assembly affixed to a portable container containing a pressure source surrounding a product bag containing minoxidil in an amount sufficient to stimulate or maintain hair growth, said minoxidil disposed within a pharmacologically acceptable carrier solution;

rotating said container and said valve assembly such that said valve assembly is at least partially below a portion of said container;

actuating said valve assembly whereby said pressure source surrounding said product bag is used to force said minoxidil and said carrier solution out of the bag; and

continuously spraying a fine mist of said minoxidil and said carrier solution onto an alopecia affected area of a scalp.

7. The method of claim 6 wherein said pharmacologically acceptable carrier solution contains less than 20% propylene glycol.

8. The method of claim 7 wherein said pharmacologically acceptable carrier solution comprises 0% propylene glycol, but does contain alcohol, glycerin, or a combination thereof.

9. The method of claim 6 wherein said carrier solution further comprises a sunscreen.

10. A spray medication, comprising an even, continuous, non-chilling, mist containing a scalp medication sufficient to stimulate or maintain hair growth on a human scalp, said scalp medication disposed within a pharmacologically acceptable carrier solution, said scalp medication being non-chilling (98.6°

F.±

5°

F.), transparent on said scalp, and not needing to be rubbed into the skin of said scalp to be effective in stimulating or maintaining said hair growth.

11. The spray medication of claim 10 wherein said carrier solution contains no propylene glycol.

12. The spray medication of claim 10 wherein said carrier solution comprises alcohol and glycerin.

13. The spray medication of claim 10 wherein said scalp medication comprises one or more of the group consisting of copper peptides, androgen receptor blockers, corticosteroids, vitamin A derivatives, tretinoin, azelaic acid, zinc, vitamin B6, grape seed extract, nicotinate, progesterone, or a combination thereof.

14. A spray medication comprising a continuous even mist including liquid droplets having an average diameter of about 1 nanometer to about 2000 micrometers, said mist containing minoxidil in an amount sufficient to stimulate or maintain hair growth, said minoxidil disposed within a pharmacologically acceptable carrier solution, said spray medication having a pH of about 4-9.

15. The spray medication of claim 14 wherein said mist comprises approximately 2-15% minoxidil in said carrier solution.

16. The spray medication of claim 15 wherein said carrier solution comprises an alcohol, an extender selected from the group consisting of propylene glycol, glycerin, dimethyl-isosorbide or a combination thereof, and purified water.

17. The spray medication of claim 14 wherein said mist further comprises a sunscreen.

18. The spray medication of claim 14 wherein said mist comprises a clear, no-rub formulation containing less than 20 wt % propylene glycol for a 2% minoxidil solution.

19. The spray medication of claim 14 further comprising a second medication selected from the group consisting of copper peptides, androgen receptor blockers, corticosteroids, vitamin A derivatives, tretinoin, azelaic acid, zinc, vitamin B6, grape seed extract, nicotinate, progesterone, or a combination thereof.

20. The spray medication of claim 14 wherein said continuous mist is generated by a pressurizing agent compressing on a product bag containing said medication.